Persistent sympathetic activation during chronic antihypertensive therapy: A potential mechanism for long term morbidity?

Qi Fu, Rong Zhang, Sarah Witkowski, Armin Arbab-Zadeh, Anand Prasad, Kazunobu Okazaki, Benjamin D Levine

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Previous studies have demonstrated that antihypertensive treatment resets baroreflex control of heart rate (HR) and increases cardiac vagal baroreflex sensitivity. However, it is uncertain whether baroreflex control of muscle sympathetic nerve activity (MSNA) also resets after treatment. We tested the hypothesis that chronic antihypertensive therapy alters baroreflex regulation of MSNA in patients with untreated moderate hypertension. Seven newly diagnosed patients with systolic blood pressure (BP) of 159±5 mm Hg (mean±SE) and diastolic BP of 103±4 mm Hg were studied before and after 1 to 2 weeks and 3 months (chronic) of antihypertensive treatment with losartan-hydrochlorothiazide (Hyzaar). MSNA and hemodynamics were measured supine, during a Valsalva maneuver (VM), and at 70° head-up tilt (HUT) for 10 minutes. Data were compared with those obtained in 7 age-matched healthy controls. We found that Hyzaar lowered mean BP acutely and chronically by 20±4 and 23±3 mm Hg (both P<0.01) but did not change HR. Supine MSNA increased by 43±11% and 34±11% after acute and chronic treatment (both P<0.01). However, MSNA responses to VM and HUT did not differ after treatment compared with before treatment, indicating unchanged reflex control. These data indicate that sympathetic neural activity was augmented substantially by antihypertensive treatment with Hyzaar, consistent with an ongoing baroreflex unloading, and did not return to baseline or "reset" after 3 months of therapy. We speculate that persistent and marked sympathetic activation by the baroreflex may be a potential mechanism for hypertension that is refractory to antihypertensive therapy and may provide a target mechanism for persistent morbidity despite adequate BP control.

Original languageEnglish (US)
Pages (from-to)513-521
Number of pages9
JournalHypertension
Volume45
Issue number4
DOIs
StatePublished - Apr 2005

Fingerprint

Antihypertensive Agents
Baroreflex
Morbidity
Blood Pressure
Muscles
Therapeutics
Valsalva Maneuver
Heart Rate
Head
Hypertension
Reflex
Hemodynamics
losartan drug combination hydrochlorothiazide

Keywords

  • Autonomic nervous system
  • Baroreceptors
  • Renin-angiotensin system

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Persistent sympathetic activation during chronic antihypertensive therapy : A potential mechanism for long term morbidity? / Fu, Qi; Zhang, Rong; Witkowski, Sarah; Arbab-Zadeh, Armin; Prasad, Anand; Okazaki, Kazunobu; Levine, Benjamin D.

In: Hypertension, Vol. 45, No. 4, 04.2005, p. 513-521.

Research output: Contribution to journalArticle

Fu, Qi ; Zhang, Rong ; Witkowski, Sarah ; Arbab-Zadeh, Armin ; Prasad, Anand ; Okazaki, Kazunobu ; Levine, Benjamin D. / Persistent sympathetic activation during chronic antihypertensive therapy : A potential mechanism for long term morbidity?. In: Hypertension. 2005 ; Vol. 45, No. 4. pp. 513-521.
@article{6adeb8914bdc41f8a994475e8639ab88,
title = "Persistent sympathetic activation during chronic antihypertensive therapy: A potential mechanism for long term morbidity?",
abstract = "Previous studies have demonstrated that antihypertensive treatment resets baroreflex control of heart rate (HR) and increases cardiac vagal baroreflex sensitivity. However, it is uncertain whether baroreflex control of muscle sympathetic nerve activity (MSNA) also resets after treatment. We tested the hypothesis that chronic antihypertensive therapy alters baroreflex regulation of MSNA in patients with untreated moderate hypertension. Seven newly diagnosed patients with systolic blood pressure (BP) of 159±5 mm Hg (mean±SE) and diastolic BP of 103±4 mm Hg were studied before and after 1 to 2 weeks and 3 months (chronic) of antihypertensive treatment with losartan-hydrochlorothiazide (Hyzaar). MSNA and hemodynamics were measured supine, during a Valsalva maneuver (VM), and at 70° head-up tilt (HUT) for 10 minutes. Data were compared with those obtained in 7 age-matched healthy controls. We found that Hyzaar lowered mean BP acutely and chronically by 20±4 and 23±3 mm Hg (both P<0.01) but did not change HR. Supine MSNA increased by 43±11{\%} and 34±11{\%} after acute and chronic treatment (both P<0.01). However, MSNA responses to VM and HUT did not differ after treatment compared with before treatment, indicating unchanged reflex control. These data indicate that sympathetic neural activity was augmented substantially by antihypertensive treatment with Hyzaar, consistent with an ongoing baroreflex unloading, and did not return to baseline or {"}reset{"} after 3 months of therapy. We speculate that persistent and marked sympathetic activation by the baroreflex may be a potential mechanism for hypertension that is refractory to antihypertensive therapy and may provide a target mechanism for persistent morbidity despite adequate BP control.",
keywords = "Autonomic nervous system, Baroreceptors, Renin-angiotensin system",
author = "Qi Fu and Rong Zhang and Sarah Witkowski and Armin Arbab-Zadeh and Anand Prasad and Kazunobu Okazaki and Levine, {Benjamin D}",
year = "2005",
month = "4",
doi = "10.1161/01.HYP.0000158312.63381.c1",
language = "English (US)",
volume = "45",
pages = "513--521",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Persistent sympathetic activation during chronic antihypertensive therapy

T2 - A potential mechanism for long term morbidity?

AU - Fu, Qi

AU - Zhang, Rong

AU - Witkowski, Sarah

AU - Arbab-Zadeh, Armin

AU - Prasad, Anand

AU - Okazaki, Kazunobu

AU - Levine, Benjamin D

PY - 2005/4

Y1 - 2005/4

N2 - Previous studies have demonstrated that antihypertensive treatment resets baroreflex control of heart rate (HR) and increases cardiac vagal baroreflex sensitivity. However, it is uncertain whether baroreflex control of muscle sympathetic nerve activity (MSNA) also resets after treatment. We tested the hypothesis that chronic antihypertensive therapy alters baroreflex regulation of MSNA in patients with untreated moderate hypertension. Seven newly diagnosed patients with systolic blood pressure (BP) of 159±5 mm Hg (mean±SE) and diastolic BP of 103±4 mm Hg were studied before and after 1 to 2 weeks and 3 months (chronic) of antihypertensive treatment with losartan-hydrochlorothiazide (Hyzaar). MSNA and hemodynamics were measured supine, during a Valsalva maneuver (VM), and at 70° head-up tilt (HUT) for 10 minutes. Data were compared with those obtained in 7 age-matched healthy controls. We found that Hyzaar lowered mean BP acutely and chronically by 20±4 and 23±3 mm Hg (both P<0.01) but did not change HR. Supine MSNA increased by 43±11% and 34±11% after acute and chronic treatment (both P<0.01). However, MSNA responses to VM and HUT did not differ after treatment compared with before treatment, indicating unchanged reflex control. These data indicate that sympathetic neural activity was augmented substantially by antihypertensive treatment with Hyzaar, consistent with an ongoing baroreflex unloading, and did not return to baseline or "reset" after 3 months of therapy. We speculate that persistent and marked sympathetic activation by the baroreflex may be a potential mechanism for hypertension that is refractory to antihypertensive therapy and may provide a target mechanism for persistent morbidity despite adequate BP control.

AB - Previous studies have demonstrated that antihypertensive treatment resets baroreflex control of heart rate (HR) and increases cardiac vagal baroreflex sensitivity. However, it is uncertain whether baroreflex control of muscle sympathetic nerve activity (MSNA) also resets after treatment. We tested the hypothesis that chronic antihypertensive therapy alters baroreflex regulation of MSNA in patients with untreated moderate hypertension. Seven newly diagnosed patients with systolic blood pressure (BP) of 159±5 mm Hg (mean±SE) and diastolic BP of 103±4 mm Hg were studied before and after 1 to 2 weeks and 3 months (chronic) of antihypertensive treatment with losartan-hydrochlorothiazide (Hyzaar). MSNA and hemodynamics were measured supine, during a Valsalva maneuver (VM), and at 70° head-up tilt (HUT) for 10 minutes. Data were compared with those obtained in 7 age-matched healthy controls. We found that Hyzaar lowered mean BP acutely and chronically by 20±4 and 23±3 mm Hg (both P<0.01) but did not change HR. Supine MSNA increased by 43±11% and 34±11% after acute and chronic treatment (both P<0.01). However, MSNA responses to VM and HUT did not differ after treatment compared with before treatment, indicating unchanged reflex control. These data indicate that sympathetic neural activity was augmented substantially by antihypertensive treatment with Hyzaar, consistent with an ongoing baroreflex unloading, and did not return to baseline or "reset" after 3 months of therapy. We speculate that persistent and marked sympathetic activation by the baroreflex may be a potential mechanism for hypertension that is refractory to antihypertensive therapy and may provide a target mechanism for persistent morbidity despite adequate BP control.

KW - Autonomic nervous system

KW - Baroreceptors

KW - Renin-angiotensin system

UR - http://www.scopus.com/inward/record.url?scp=15744381486&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15744381486&partnerID=8YFLogxK

U2 - 10.1161/01.HYP.0000158312.63381.c1

DO - 10.1161/01.HYP.0000158312.63381.c1

M3 - Article

C2 - 15738344

AN - SCOPUS:15744381486

VL - 45

SP - 513

EP - 521

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 4

ER -